Co-polymerised peptide particles II: Oral uptake of a novel co-polymeric nanoparticulate delivery system for peptides

Journal of Controlled Release

Volumn 42, Issue 1, 1996, Pages 65-73

  Hillery, Anya M ^a,b   Toth, Istvan ^a   Florence, Alexander T ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

Gel filtration chromatography; Luteinizing hormone releasing hormone; Nanoparticles; Oral drug delivery; Radioimmunoassay

Indexed keywords

COPOLYMER; GONADORELIN DERIVATIVE; NANOPARTICLE; PEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; DRUG DELIVERY SYSTEM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0030271533     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(96)01368-5     Document Type: Article

References (37)

1. [1] A.M. Hillery, I. Toth, A.M. Shaw and A.T. Florence, Copolymerised peptide particles: synthesis, characterisation and in vitro studies on a novel oral nanoparticulate delivery system, J. Control. Rel. (1996) in press.
2. [2] D.T. O'Hagan, Intestinal translocation of particulates: implications for drug and antigen delivery, Adv. Drug Del. Rev. 5 (1990) 265-285.
3. [3] A.T. Florence and P.U. Jani, Particulate delivery: the challenge of the oral route. in: A. Rolland (Ed.) Pharmaceutical Particulate Carriers, Therapeutic Applications, Marcel Dekker, New York, 1993, pp. 65-107.
4. [4] J. Kreuter, Peroral administration of nanoparticles, Adv. Drug Del. Rev. 7 (1991) 71-86.
5. [5] P.A. Flanagan, P. Kopeckova, J. Kopecek and R. Duncan, Evaluation of protein-N-(2-hydroxypropyl)methacrylamide copolymer conjugates as targetable drug carriers. 1. Binding, pinocytic uptake and intracellular distribution of transferrin and anti-transferrin receptor antibody conjugates. Biochim. Biophys. Acta. 933 (1989) 83-91.
6. [6] L.M. Sanders, Controlled delivery systems for peptides, in: V.H.L. Lee (Ed.) Peptide and Protein Drug Delivery, Marcel Dekker, New York, 1991, pp. 785-806.
7. [7] J. Kopecek, P. Kopecova, H. Brønsted, R. Rathi, B. Rihova, P.Y. Yeh and K. Ikesue, Polymers for colon-specific drug delivery. J. Control. Rel. 19 (1992) 121-130.
8. [8] P. Kopeckova, R. Rathi, S. Takada, B. Rihova, M.M. Berenson and J. Kopecek. Bioadhesive N-(2-hydroxypropyl)methacrylamide copolymers for colon-specific drug delivery, J. Control. Rel. 28 (1994) 211-222.
9. [9] P. Couvreur, B. Kante, M. Roland, P. Guiot, P. Bauduin and P. Speiser, Polycyanoacrylate nanocapsules as potential lysomotropic carriers: preparation, morphological and sorptive properties. J. Pharm. Pharmacol. 31 (1979) 331-332.
10. [10] C.S. Randall, T.R. Malefyt and L.A. Sternson, Approaches to the analysis of peptides, in: V.H.L. Lee (Ed.) Peptide and Protein Drug Delivery, Marcel Dekker. New York, 1991, pp. 203-246.
11. [11] J.M. Samanen, Physical biochemistry of peptide drugs: structure, properties, and stabilities of peptides compared with proteins, in: V.H.L. Lee (Ed.) Peptide and Protein Drug Delivery. Marcel Dekker, New York, 1991, pp. 137-166.
12. [12] A.M. Hillery, P.U. Jani and A.T. Florence. Comparative quantitative study of lymphoid and non-lymphoid uptake of 50 nm polystyrene particles. J. Drug Target. 2 (1994) 151-156.
13. [13] B.M. Mitruka and H.M. Rawnsley (Eds.) Clinical biochemical and hematological reference values in normal experimental animals, Masson, New York, 1977 pp. 14.
14. [14] M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein binding. Anal. Biochem. 72 (1976) 248-254.
15. [15] B.H. Vickery, Comparison of the potential for therapeutic utilities with gonadotropin-releasing hormone agonists and antagonists, Endocr. Rev. 7 (1986) 115-124.
16. [16] P.G. Jenkins, K.A. Howard, N.W. Blackhall, N.W. Thomas, S.S. Davis and D.T. O'Hagan, The quantitation of the absorption of microparticles into the intestinal lymph of Wistar rats, int. J. Pharm. 102, 261-266.
17. [17] D.T, O'Hagan, N.M. Christy and S.S. Davis, Particulates and lymphatic drug delivery, in: W.N. Charman and V.J. Stella (Eds.) Lymphatic Transport of Drugs, CRC Press, Boca Raton 1992, pp. 279-315.
18. [18] J.C. Gautier, J.L. Grangier, A. Barbier, P. Dupont, D. Dussossoy, G. Pastor and P. Couvreur, Biodegradable nanoparticles for subcutaneous administration of growth hormone releasing factor (hGRF), J. Control. Rel. 20 (1992) 67-78.
19. [19] D.J. Handelsman and R.S. Swerdloff. Pharmacokinetics of gonadotropin-releasing hormone and its analogues, Endocr. Rev. 7 (1986) 95-105.
20. [20] C.P. Fawcett, E.A. Beezley and J.E. Wheaton, Detection of a second form of luteinizing hormone releasing factor. Int. Res. Commun. Sy. Libr. Compend. 2 (1974) 1663.
21. [21] K.G. de la Cruzs and A. Arimura. Evidence for the presence of immunoreactive plasma LH-RH which is unrelated to LH-RH decapeptide, Proc. 57th Ann. Meeting Endocrine Soc, New York, 1975, p. 103 (abstract).
22. [22] K. Elkind-Hirsch, V. Ravnikar, I. Schiff, D. Tulchinsky and K.J. Ryan, Determination of endogenous immunoreactive luteinizing hormone-releasing hormone in human plasma, J. Clin. Endocrinol. Metab. 54 (1982) 602-607.
23. [23] A. Arimura, A.J. Kastin, D. Gonzales-Barcena, D.H. Coy, E.J. Coy, D.S. Schaich and A.V. Schally. Disappearance of LH-releasing hormone in man as determined by radio-immunoassay, Clin. Endocrinol. 3 (1974) 421-425.
24. [24] A. Amiura, A.J. Kastin, A.V. Schally, M. Salto, T. Kumasada, N. Nishi and K. Okhura. Immunoreactive LH-releasing hormone in plasma: Mid-cycle elevation in women. J. Clin. Endocrinol. Metab. 38 (1974) 510-513.
25. [25] T.M. Nett and G.D. Niswender, Gonadotropin-releasing hormone, in: B.W. Jaffe and H.R. Behrman (Eds.) Methods of Hormone Radioimmunoassay, 2nd Edition, Academic Press, New York, 1979, pp. 57-75.
26. [26] P.J. Lowe and C.S. Temple, Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats, J. Pharm. Pharmacol. 46 (1994) 547-552.
27. [27] C. Damgé, C. Michel, M. Aprahamian and P. Couvreur, New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier, Diabetes 37 (1988) 246-251.
28. [28] P. Maincent, R. Le Verge, P. Sado, P. Couvreur and J.P. Devissaguet, Disposition kinetics and oral bioavailability of vincamine-loaded polyalkylcyanoacrylate nanoparticles, J. Pharm. Sci. 10 (1986) 965-968.
29. [29] M. Aprahamian, C. Michel, W. Humbert, J.P. Devissaguet and C. Damgé. Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine, Biol. Cell. 61 (1987) 69-76.
30. [30] N. Ammoury, H. Fessi, J.P. Devissaguet, M. Allix, M. Plotkine and R.G. Boulu. Effect on cerebral blood flow of orally administered indomethacin-loaded poly-(isobutylcyanoacrylate) and poly (DL-lactide) nanocapsules, J. Pharm. Pharmacol. 42 (1990) 558-561.
31. [31] A.M. Hillery, I. Toth and A.T. Florence, Co-polymerised peptide particles (CPP) III: Biological evaluation of a novel nanoparticulate peptide delivery system using luteinizing hormone releasing hormone (LHRH), Pharm. Sci. (1996) in press.
32. [32] C. Manieri, A.R. Marolda, M. Musso, R. Pastorino and M. Messina, The GnRH 10 micrograms test promotes a maximal gonadotropic response in normal women, Gynecol. Endocrinol. 6 (1992) 167-170.
33. [33] R.H. Müller, C. Lherm, J. Herbort and P. Couvreur, In vitro model for the degradation of alkylcyanoacrylate nanoparticles. Biomaterials 11 (1990) 590-595.
34. [34] J.L. Grangier, M. Puygrenier, J.C. Gautier and P. Couvreur, Nanoparticles as carriers for growth hormone releasing factor, J. Control. Rel. 15 (1991) 3-13.
35. [35] L. Tharandt, H. Schulte, G. Benker, K. Hackenburg and D. Reinwein, Binding of luteinizing hormone releasing hormone to human serum proteins - influence of a chronic treatment with a more potent analogue of LHRH, Horm. Metab. Res. 11 (1979) 391-394.
36. [36] R.L. Chan and M.D. Chaplin. Plasma binding of LHRH and nafarelin acetate, a highly potent LHRH agonist, Biochem. Biophys. Res. Commun. 127 (1985) 673-679.
37. [37] F.A. Carone, D.R. Peterson and G. Flouret. Renal tubular processing of small peptide hormones, J. Lab. Clin. Med. 100 (1982) 1-14.